Painchek (ASX:PCK) 9-Day RSI: 29.12 (As of Jun. 30, 2026)


What is Painchek 9-Day RSI?

Painchek ASX:PCK -3.00% 9-Day RSI is 29.12 as of Jun. 30, 2026. The stock has 3 warning signs investors should review. Among 699 Healthcare Providers & Services companies, Painchek ranks better than 81.12% on this metric.

The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.

As of today (2026-06-30), Painchek's 9-Day RSI is 29.12.

The industry rank for Painchek's 9-Day RSI or its related term are showing as below:

ASX:PCK's 9-Day RSI is ranked better than
81.12% of 699 companies
in the Healthcare Providers & Services industry
Industry Median: 47.47 vs ASX:PCK: 29.12

Painchek  (ASX:PCK) 9-Day RSI Explanation

The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.

Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.

RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.


Painchek 9-Day RSI Related Terms


ASX:PCK vs VEEV, BTSG, TEM: 9-Day RSI Comparison

For the Health Information Services subindustry, Painchek's 9-Day RSI, along with its competitors' market caps and 9-Day RSI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Painchek 9-Day RSI vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Painchek's 9-Day RSI distribution charts can be found below:

* The bar in red indicates where Painchek's 9-Day RSI falls into.



Painchek  (ASX:PCK) 9-Day RSI Calculation

The formula for calculating RSI is:

RSI=100[ 100 / ( 1 + Average Gain / Average Loss )]

* Note that the formula uses a positive value for the average loss.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about 9-Day RSI →
What does a 9-Day RSI of 29.12 mean?
Painchek (ASX:PCK) has a 9-Day RSI of 29.12 as of Jun. 30, 2026. According to the industry distribution chart, Painchek ranks #132 out of 699 companies in the Healthcare Providers & Services industry, placing it in the top 18.9%.
Is Painchek's 9-Day RSI too high?
Painchek's current 9-Day RSI is 29.12. The Healthcare Providers & Services industry median 9-Day RSI is 47.47. Painchek's value of 29.12 is 38.7% below this industry median. Based on the distribution chart, Painchek ranks #132 out of 699 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers.
How does Painchek's 9-Day RSI compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Painchek ranks #132 out of 699 companies for 9-Day RSI. This places Painchek in the top 19% of its industry — outperforming the majority of peers. The industry median 9-Day RSI is 47.47. Painchek's value of 29.12 is 38.7% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 9-Day RSI for a Healthcare Providers & Services company?
The median 9-Day RSI among Healthcare Providers & Services companies is 47.47, based on 699 companies in the industry. Companies in the top quartile (top 25%) have a 9-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 9-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Painchek's current 9-Day RSI of 29.12 is 38.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 9-Day RSI mean?
A high 9-Day RSI can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median 9-Day RSI is 47.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Painchek's current 9-Day RSI is 29.12. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Painchek stock overvalued right now?
Based on GuruFocus' analysis, Painchek (ASX:PCK) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.40, compared to a current price of A$0.10 — trading 75.8% below its estimated fair value. The current 9-Day RSI is 29.12 and 38.7% below the Healthcare Providers & Services industry median of 47.47. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 9-Day RSI calculated?
9-Day RSI is calculated from a company's financial statements. For Painchek (ASX:PCK), the current 9-Day RSI is 29.12 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Painchek Business Description

Address 35 Lime Street, Suite 401, Sydney, NSW, AUS, 2000
Painchek Ltd is engaged in the development and commercialization of mobile medical device applications that provide pain assessment for individuals who are unable to communicate pain with carers. It operates in one segment, namely the sale of its pain assessment solutions. Its geographic segments include Australia, the United Kingdom, and Other countries, of which it generates the majority of its revenue from Australia.